13D Filing: Wincrest Capital Ltd. and Tecogen Inc. (TGEN)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

The Securities Exchange Act of 1934
(Amendment No. 2)*

Tecogen Inc.
(Name of Issuer)

Common Stock
(Title of Class of Securities)

87876P201
(CUSIP Number)

Barbara Ann Bernard
Wincrest Capital Ltd.
7 Old Fort Bay Town Centre
Nassau, The Bahamas
(242) 603-2015

As of September 5, 2017

If the filing person has previously filed a statement 13G to report the
acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of ss.240.13D-1(e), 240.13D-1(f), or 240.13D-1(g), check
the following box [__].

Note: Schedules filed in paper format shall include a signed original and
five copies of the schedule, including all exhibits. See Rule 13d-7 for
other parties to whom copies are to be sent.

_________
*The remainder of this cover page shall be filled out for a reporting
person’s initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be
deemed to be “filed” for the purpose of Section 18 of the Securities
Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).